61/1025/2026 - Supersaturated Solution of Calcium Phosphate Ions, Oral Solution A+B

This tender, referenced as 61/1025/2026, concerns the procurement of a specific pharmaceutical product: a supersaturated solution of calcium phosphate ions, provided as an oral solution labeled A+B. The objective is to acquire this specialized medical solution, likely used for therapeutic purposes related to calcium and phosphate balance or bone health. The tender specifies the exact formulation and presentation required. Interested suppliers are expected to provide this product in compliance with all relevant quality, safety, and regulatory standards for pharmaceutical preparations. The procurement process will involve evaluating bids based on the ability to supply the specified product, adherence to quality specifications, delivery timelines, and pricing. This acquisition is crucial for ensuring that patients requiring this particular treatment have access to it through the designated healthcare channels. The tender documentation will detail the precise quantities and delivery requirements.

This is a supplies contract in the health and medical services, information and communication technology and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 3,750.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.